Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00350441|
Recruitment Status : Unknown
Verified July 2006 by NHS Greater Glasgow Yorkhill Division.
Recruitment status was: Recruiting
First Posted : July 10, 2006
Last Update Posted : October 11, 2006
|Condition or disease||Intervention/treatment||Phase|
|Cardiopulmonary Bypass||Drug: Sildenafil Citrate||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||12 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study of the Pre-Operative Effect of Sildenafil Citrate on Pulmonary Related Complications Following Cardiopulmonary Bypass in Children Undergoing Cardiac Surgical Repair.|
|Study Start Date :||June 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00350441
|Contact: Tony Vassalos, MB Ch B||0141 201 email@example.com|
|Royal Hospital for Sick Children||Recruiting|
|Glasgow, Strathclyde, United Kingdom, G3 8SJ|
|Contact: Tony Vassalos 0141 201 1000 firstname.lastname@example.org|
|Contact: Mark Danton 0141 201 1000 email@example.com|
|Principal Investigator: Tony Vassalos|
|Principal Investigator:||Tony Vassalos, MB Ch B||Royal Hospital for Sick Children|